Shuttle Pharmaceuticals Holdings, Inc.

SHPH Nasdaq SEC CIK 1757499
Follow Shuttle Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Net income −$3.1M +15.1% vs same quarter last year
EPS, diluted −$3.10
Operating cash flow −$567.6K +83.1% vs same quarter last year
Operating income −$3.9M −1% vs same quarter last year
Net income by quarter
−$3.8M
−$1.6M
−$3.1M
−$3.7M
−$2.3M
−$2.6M
−$2.2M
−$3.1M
Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
−$15M−$10M−$5M$0FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$11.7M
FY24−$9.1M
FY23−$6.6M
FY22−$5M
FY21−$1.2M
FY20-